Jeffrey Robb

Nebraska Medicine announces transformation, digital officer

In the new executive role, Michael Hasselberg, PhD, will drive digital innovation and elevate patient care across Nebraska Medicine.  

Aug 8, 2025

Michael Hasselberg, PhD

New business and finance website is live

The public website offers a central online location for information on a range of services and functions.

Aug 8, 2025

Anne Barnes, vice chancellor for business, finance and business development

Traffic update for 42nd and Emile Streets

Additional interruptions will start on Monday, Aug. 11, and last for three weeks.

Aug 8, 2025

traffic safety roadwork signs and light

UNMC for the record, Aug. 8, 2025

Campus news on an op-ed by Dr. Davies, a sale at the UNMC Bookstore and an important mailing change.

Aug 8, 2025

Interim Chancellor H. Dele Davies, MD

UNMC achievements, Aug. 8, 2025

Two hall of famers and awards for a gastroenterology team and iEXCEL.

Aug 8, 2025

Jonathan Vennerstrom, PhD

Ask UNMC! Eric Ernest, MD, UNMC College of Medicine

What’s the difference between heat stroke and heat exhaustion?

Aug 7, 2025

Eric Ernest, MD, UNMC College of Medicine

Tammie Vargo, DHA, is new chair of dental hygiene

Dr. Vargo began her new role with the UNMC College of Dentistry on July 1.

Aug 7, 2025

Tammie Vargo, DHA

Changes are coming to how phishing emails are handled 

Users who submit emails for phishing attempts now will receive an email reply letting them know if it was malicious or not.

Aug 7, 2025

A person typing on a computer

High Plains Radio on Aug. 6

University of Nebraska Medical Center Interim Chancellor Dr. Dele Davies visits with McCook leaders on issues and initiatives impacting rural Nebraska

Aug 6, 2025

Interim Chancellor H. Dele Davies, MD

Nebraska Medicine patient is first to receive new MS therapy

A first-of-its-kind clinical trial is examining the effectiveness of allogeneic CAR T-Cell therapy.

Aug 6, 2025

Nebraska Medicine patient Jan Janisch-Hanzlik is first in the world to receive a new allogeneic CAR T-Cell therapy for multiple sclerosis.